Simon Cancer Institutes on Muck Rack

Simon Cancer Institutes

As seen in: Oxford Academic
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Simon Cancer

Contact Simon Cancer, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma

|
By Newport Beach, Na Tosha N, Simon Cancer Institutes, Huda Ismail
| Oxford Academic Verified
Glioblastoma (GBM) is the most common primary central nervous system (CNS) malignancy.1 In addition to surgery, radiotherapy (RT), and chemotherapy, the noninvasive, locoregionally applied, anticancer treatment modality of Tumor Treating Fields (TTFields) therapy (Optune Gio) is approved for newly diagnosed (nd) GBM (concomitant with maintenance temozolomide [TMZ] chemotherapy) and recurrent (r) GBM (as a monotherapy), in the United States (by the US Food and Drug Administration [FDA]),...
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified